[纳瓦拉的癌症患者的生存率和与西班牙的比较]
Marcela Guevara1, Miren Baztan2, Rosana Burgui3
1Instituto de Salud Pública y Laboral de Navarra. mp.guevara.eslava@navarra.es.
Anales del sistema sanitario de Navarra
|August 18, 2023
概括
从1999-2007年到2008-2016年,纳瓦拉的癌症患者生存率显著改善,女性和纳瓦拉的生存率高于西班牙的总体.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 分析了西班牙纳瓦拉州成年癌症患者的生存率.
- 描述随着时间的推移生存趋势.
- 与西班牙国家生存率数据进行比较.
研究的目的:
- 为了分析纳瓦拉的癌症患者生存率.
- 描述纳瓦拉的生存趋势.
- 为了将纳瓦拉的生存数据与西班牙的数据进行比较.
主要方法:
- 利用了纳瓦拉州1999-2007年和2008-2016年的基于人口的癌症登记数据.
- 生命状况更新至2020年.
- 总和特定癌症组的五年观察,净和年龄标准化净存活率估计.
主要成果:
- 分析了57,564例;2008-2016年年龄标准化净生存率为59.9% (男性) 和63.8% (女性).
- 根据癌症类型的生存率差异很大,男性的生存率从13.4% (胰腺) 到94.0% (甲状腺),女性的生存率从11.9% (肝脏) 到95.6% (甲状腺).
- 总体而言,年龄标准化净生存率比上一时期增加了5.1个百分点,纳瓦拉的生存率比西班牙 (2008-2013) 高2.7个百分点.
结论:
- 与1999-2007年相比,纳瓦拉的癌症患者存活率在2008-2016年期间显著改善.
- 改善可能归因于早期诊断,先进的治疗方法和增强的医疗保健.
- 纳瓦雷的癌症存活率高于西班牙,女性的癌症存活率通常比男性更好.
相关概念视频
01:21Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
01:20Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:18Survival Curves
196
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
196
01:24Kaplan-Meier Approach
179
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
179